Janus Henderson Equity Linked Moderate Income ETF (JELM)

What an absolutely moronic statement to make 🤣

You are clearly unaware the UK Agencies auditing this application, very much monitored this forum, to get a 'coal face' picture of MWBO 'The Company'.

Anyway, its been a day since desperate investors pestered them f

/

Hope4Patients reposted
alphavestcapital.com
@alphavestcap
by The Danish Dude:
$nwbo
@alphavestcap


Northwest Biotherapeutics will present major findings at the British Neuro-Oncology Society conference, with Dr. Marnix Bosch delivering resul

As someone already pointed out, payment could have been made by credit card, debit card also.

No payment could come from a bank under a garnishment order.

Forrester: Nine In 10 US Marketing Agencies Use AI To Cut Costs At The Expense Of CreativityJune 24, 2026 3:00 AM
Business Wire New research calls on agencies and CMOs to shift their focus from AI-driven cost savings to preserving creativity and differentiation

Takeda Announces New Assignments of Directors and Appointment of Julie Kim as Representative Director, President and CEOJune 24, 2026 3:05 AM
Business Wire Board of Directors appoints Julie Kim as Representative Director, President & CEO following share

Signatera™ Receives Regulatory Approval in Japan for Colorectal CancerJune 24, 2026 3:00 AM
Business Wire First PMDA-approved molecular residual disease (MRD) test in Japan, supporting the use of Signatera in the adjuvant setting Commer

If you want the cheapest shares you can get? One would think
that would entail being patient for it to confirm a BOTTOM is in before
buying shares (aka, the 'cheapest' you would be able to get em).

I have no idea where this is going to stop sliding at. Just playing t

Likely strategic move to avoid OTC

Notice how they’re going from NASDAQ to NYSE

I am betting on 3 team parlay, Jason Kalisman, Atlanta Braves and New York Yankees, although I don't know much about baseball, but I do have my favorite, Anaheim Angels. Welp, off to bed, going to have great night sleep after listening to "I found my love in Portofino" by Andrea Bocelli.

Thank you, Mr Bystander. I would reckon this is only the start of the infighting and many similar cases are in the pipeline.

Has anyone ever Googled the address and looked on maps where the LLCs that bought professor Li's shares is located? It's a shack in Florida. I'm so glad I woke up. 😆 
2804 Dawley Ave, Orlando, FL 32806

Have one on the House! 🍻HEAR, HEAR. VeeMo $ t

MSCI Acquires First Street to Enhance Physical Climate Risk Capabilities for Financial Decision MakingJune 24, 2026 2:33 AM
Business Wire MSCI Inc. (NYSE: MSCI) is enhancing its global physical climate risk capabilities with the acquisition of First Street, a leading provider o

He has/had every right to be. However, I hope he can let this go and move on. These people are not worth the sweat off his sack.

I would have loved a deal already, especially one that would have avoided a raise at 10 dollars. That said right now the type of deal you might pursue very well may depend on a few factors that are around the corner. The two lawsuits, and the first clinical readout in immunology. That might give you

The importance of critical minerals ! Mrima Hill rare earth and niobium deposit ...
>>> "Every major power understands that whoever controls the supply chains controls the future."
https://www.armstrongeconomics.com/international-news/africa/us-strikes-deal-for-kenyas-rare-earth-miner

I'm leaning towards not. I was invested in this thing for a long time. I've been to the shareholder meetings, spoke with the executives, shook professor Li's hand, had breakfast with Tony and I'm convinced there is a very slight chance this company will ever be profitable. The technology is amazing!

Is Elon Musk like Henry Ford? Does he want to be like Henry Ford??

If MHRA did find the application was bogus… as you suggest… then they are corrupt, or just idiots.

Echoes of EDP-235.

As Dew said, Zeli isn't close to what happened with EDP-235 as Zeli not only completed phase 2 with stellar results for high risk but has been given the go ahead given for phase 3.EDP-235 only had early stage trial data.. Add in that Paxlovid was already on the mark